Litcius/Paper detail

Probiotic Bifidobacterium lactis Probio-M8 treated and prevented acute RTI, reduced antibiotic use and hospital stay in hospitalized young children: a randomized, double-blind, placebo-controlled study

Mageswaran Uma Mageswary, Xin-Yee Ang, Boon-Kiat Lee, Yi-Li Fiona Chung, Siti Nur Afiqah Azhar, Intan Juliana Abd Hamid, H. Abu Bakar, Nurhanis Syazni Roslan, Xiaojun Liu, Xiaohong Kang, Lu Dai, Sasidharan Sreenivasan, Fahisham Taib, Heping Zhang, Min‐Tze Liong

2021European Journal of Nutrition32 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePlaceboProbioticAntibioticsRespiratory tract infectionsRandomized controlled trialInternal medicineBifidobacteriumMedical prescriptionPlacebo-controlled studyRespiratory systemLactobacillusDouble blindPharmacologyAlternative medicineBacteriaGeneticsPathologyMicrobiologyBiologyInfant Health and DevelopmentProbiotics and Fermented FoodsPediatric health and respiratory diseases
Probiotic Bifidobacterium lactis Probio-M8 treated and prevented acute RTI, reduced antibiotic use and hospital stay in hospitalized young children: a randomized, double-blind, placebo-controlled study | Litcius